Aethlon Retained Earnings vs Common Stock Shares Outstanding Analysis
AEMD Stock | USD 1.18 0.07 5.60% |
Aethlon Medical financial indicator trend analysis is way more than just evaluating Aethlon Medical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aethlon Medical is a good investment. Please check the relationship between Aethlon Medical Retained Earnings and its Common Stock Shares Outstanding accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.
Retained Earnings vs Common Stock Shares Outstanding
Retained Earnings vs Common Stock Shares Outstanding Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aethlon Medical Retained Earnings account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Aethlon Medical's Retained Earnings and Common Stock Shares Outstanding is -0.69. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of Aethlon Medical, assuming nothing else is changed. The correlation between historical values of Aethlon Medical's Retained Earnings and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of Aethlon Medical are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Retained Earnings i.e., Aethlon Medical's Retained Earnings and Common Stock Shares Outstanding go up and down completely randomly.
Correlation Coefficient | -0.69 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Most indicators from Aethlon Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aethlon Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.At present, Aethlon Medical's Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 0.44, whereas Sales General And Administrative To Revenue is forecasted to decline to 12.03.
Aethlon Medical fundamental ratios Correlations
Click cells to compare fundamentals
Aethlon Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aethlon Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 10.4M | 10.7M | 19.4M | 17.5M | 20.1M | 21.1M | |
Other Current Liab | 584.1K | 880.2K | 852.6K | 588.6K | 676.9K | 643.0K | |
Total Current Liabilities | 1.1M | 1.4M | 1.8M | 1.5M | 1.7M | 1.6M | |
Total Stockholder Equity | 9.4M | 9.4M | 17.1M | 15.1M | 17.3M | 18.2M | |
Net Debt | (9.5M) | (9.8M) | (16.3M) | (13.3M) | (12.0M) | (11.4M) | |
Retained Earnings | (112.0M) | (119.9M) | (130.3M) | (142.4M) | (128.1M) | (121.7M) | |
Cash | 9.6M | 9.9M | 17.1M | 14.5M | 16.7M | 17.5M | |
Non Current Assets Total | 346.6K | 317.2K | 1.3M | 2.4M | 2.8M | 2.9M | |
Cash And Short Term Investments | 9.6M | 9.9M | 17.1M | 14.5M | 16.7M | 17.5M | |
Common Stock Total Equity | 17.7K | 19.0K | 9.4K | 12.2K | 14.0K | 13.3K | |
Common Stock Shares Outstanding | 341.5K | 1.2M | 1.5M | 2.1M | 2.4M | 2.5M | |
Liabilities And Stockholders Equity | 10.4M | 10.7M | 19.4M | 17.5M | 20.1M | 21.1M | |
Other Stockholder Equity | 121.4M | 129.3M | 147.4M | 163.5M | 188.1M | 197.5M | |
Total Liab | 1.1M | 1.4M | 2.4M | 2.4M | 2.8M | 4.1M | |
Total Current Assets | 10.0M | 10.4M | 18.2M | 15.1M | 17.4M | 18.2M | |
Common Stock | 9.4K | 12.2K | 15.4K | 23.0K | 26.4K | 39.5K | |
Property Plant And Equipment Net | 276.9K | 201.3K | 1.1M | 2.3M | 2.6M | 2.8M | |
Accounts Payable | 285.0K | 337.7K | 500.0K | 432.9K | 389.6K | 563.8K | |
Property Plant And Equipment Gross | 276.9K | 201.3K | 1.1M | 2.3M | 2.6M | 2.8M | |
Intangible Assets | 57.5K | 57.0K | 2.2K | 1.7K | 1.5K | 1.4K | |
Short Long Term Debt Total | 141.1K | 42.5K | 729.4K | 1.2M | 1.1M | 936.2K | |
Other Current Assets | 229.6M | 341.1M | 956.6K | 557.6K | 641.3K | 609.2K | |
Accumulated Other Comprehensive Income | (368.3K) | (385.5K) | 0.0 | (6.1M) | (5.5M) | (5.3M) | |
Short Term Debt | 98.6K | 42.5K | 126.9K | 269.4K | 242.4K | 230.3K | |
Property Plant Equipment | 140.5K | 201.3K | 1.1M | 2.3M | 2.6M | 2.8M | |
Non Current Liabilities Total | 42.5K | 495.1K | 602.5K | 939.6K | 1.1M | 1.1M | |
Net Tangible Assets | 9.4M | 9.4M | 17.1M | 15.1M | 17.3M | 18.2M | |
Noncontrolling Interest In Consolidated Entity | (101.2K) | (126.0K) | (132.1K) | (136.9K) | (123.2K) | (117.1K) | |
Retained Earnings Total Equity | (99.5M) | (105.7M) | (112.0M) | (119.9M) | (107.9M) | (113.3M) | |
Capital Surpluse | 105.6M | 108.1M | 121.4M | 129.3M | 148.7M | 97.7M |
Pair Trading with Aethlon Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aethlon Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aethlon Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Aethlon Stock
0.88 | CVS | CVS Health Corp | PairCorr |
0.83 | NRC | National Research Corp | PairCorr |
0.84 | MASS | 908 Devices Financial Report 14th of May 2024 | PairCorr |
Moving against Aethlon Stock
0.86 | AZN | AstraZeneca PLC ADR | PairCorr |
0.65 | ELDN | Eledon Pharmaceuticals | PairCorr |
0.44 | FBRX | Forte Biosciences Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Aethlon Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aethlon Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aethlon Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aethlon Medical to buy it.
The correlation of Aethlon Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aethlon Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aethlon Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aethlon Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Aethlon Stock analysis
When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Aethlon Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.01) | Revenue Per Share 0.236 | Quarterly Revenue Growth 42.782 | Return On Assets (0.47) | Return On Equity (0.98) |
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.